- Home
- ARVN vs NWBI Comparison
ARVN vs NWBI Comparison
Compare ARVN & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- NWBI
- Stock Information
- Founded
- ARVN 2015
- NWBI 1896
- Country
- ARVN United States
- NWBI United States
- Employees
- ARVN N/A
- NWBI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- NWBI Major Banks
- Sector
- ARVN Health Care
- NWBI Finance
- Exchange
- ARVN Nasdaq
- NWBI Nasdaq
- Market Cap
- ARVN 1.7B
- NWBI 1.6B
- IPO Year
- ARVN 2018
- NWBI N/A
- Fundamental
- Price
- ARVN $27.04
- NWBI $13.81
- Analyst Decision
- ARVN Strong Buy
- NWBI Hold
- Analyst Count
- ARVN 15
- NWBI 3
- Target Price
- ARVN $57.50
- NWBI $11.67
- AVG Volume (30 Days)
- ARVN 562.1K
- NWBI 665.3K
- Earning Date
- ARVN 11-05-2024
- NWBI 10-29-2024
- Dividend Yield
- ARVN N/A
- NWBI 5.84%
- EPS Growth
- ARVN N/A
- NWBI N/A
- EPS
- ARVN N/A
- NWBI 0.80
- Revenue
- ARVN $93,300,000.00
- NWBI $491,907,000.00
- Revenue This Year
- ARVN $179.49
- NWBI N/A
- Revenue Next Year
- ARVN N/A
- NWBI $6.25
- P/E Ratio
- ARVN N/A
- NWBI $17.09
- Revenue Growth
- ARVN N/A
- NWBI N/A
- 52 Week Low
- ARVN $13.57
- NWBI $9.80
- 52 Week High
- ARVN $53.08
- NWBI $14.55
- Technical
- Relative Strength Index (RSI)
- ARVN 59.76
- NWBI 65.29
- Support Level
- ARVN $25.42
- NWBI $12.79
- Resistance Level
- ARVN $29.24
- NWBI $13.05
- Average True Range (ATR)
- ARVN 1.21
- NWBI 0.27
- MACD
- ARVN 0.29
- NWBI 0.09
- Stochastic Oscillator
- ARVN 58.72
- NWBI 99.07
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and banking business solutions, investment management, trust services and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.